YWHAG Antibodies are immunoreagents designed to detect and quantify the YWHAG protein, which plays critical roles in cell cycle control, apoptosis, and transcriptional regulation . These antibodies are essential tools for studying YWHAG's interaction with client proteins such as CDC25 phosphatases and RAF kinases .
YWHAG Antibodies are rigorously validated using multiple methodologies:
Disease Research: YWHAG dysregulation is linked to cancers and neurodegenerative disorders. Antibodies enable detection of aberrant expression in clinical samples .
Therapeutic Development: While no YWHAG-targeted therapies are in clinical trials, antibody engineering platforms (e.g., recombinant DNA technology) explore its potential in drug delivery systems .
ywjG Antibody (product code CSB-PA361898XA01BRJ) is a research reagent developed against the ywjG protein (UniProt accession number P06629) found in Bacillus subtilis strain 168 . The ywjG protein belongs to a family of bacterial proteins involved in cell wall synthesis and maintenance. This antibody serves as a valuable tool for detecting and studying ywjG protein expression, localization, and function in bacterial systems. The antibody is available in both concentrated (0.1ml) and diluted (2ml) formats to accommodate different experimental needs .
ywjG Antibody is primarily utilized in research applications focusing on bacterial physiology and pathogenesis. Common experimental applications include:
Western blotting for ywjG protein detection and quantification
Immunoprecipitation for protein-protein interaction studies
Immunohistochemistry for localization studies
ELISA-based assays for quantitative analysis
Bacterial infection diagnostic applications
The antibody enables detection of bacterial antigenic components through antigen-antibody complex formation under appropriate experimental conditions . This makes it particularly valuable for researchers investigating Bacillus subtilis cellular processes, bacterial infection mechanisms, and potential antimicrobial targets.
ywjG Antibody can be employed with various detection methodologies depending on the research objective:
| Detection Method | Applications | Sensitivity Range | Recommended Controls |
|---|---|---|---|
| Western Blotting | Protein expression levels, molecular weight confirmation | 5-500 ng protein | Positive control (purified ywjG), negative control (non-expressing strain) |
| Immunofluorescence | Protein localization, co-localization studies | N/A | Secondary antibody-only control, non-expressing strain |
| ELISA | Quantitative protein detection | 0.5-500 ng/ml | Standard curve with recombinant protein |
| Flow Cytometry | Cell population analysis | N/A | Isotype control, unstained control |
| Immunoprecipitation | Protein complex isolation | 50-500 μg total protein | IgG control, pre-immune serum |
For reliable detection, researchers should use stable conditions that support antigen-antibody complex formation as described in antibody-based methods for detecting bacterial components .
Proper storage and handling of ywjG Antibody is critical for maintaining its activity and specificity. Following standard protocols for antibody preservation:
Store concentrated antibody aliquots at -20°C for long-term storage
Working dilutions can be maintained at 4°C for up to two weeks
Avoid repeated freeze-thaw cycles (limit to <5 cycles)
Supplement storage buffer with protease-free BSA (0.1-1%) to prevent adsorption to container surfaces
Centrifuge all antibody solutions before use to remove aggregates
For dilutions, use sterile buffers containing preservatives such as 0.02% sodium azide
Proper handling ensures experimental reproducibility and extends the functional lifespan of the antibody reagent.
For immunoprecipitation (IP) experiments with ywjG Antibody, researchers should follow this methodological approach:
Sample preparation: Prepare bacterial lysates from Bacillus subtilis cultures in a non-denaturing lysis buffer (typically containing 150mM NaCl, 50mM Tris-HCl pH 7.5, 1% NP-40 or equivalent, and protease inhibitors).
Pre-clearing: Incubate lysate with Protein A/G beads (without antibody) for 1 hour at 4°C to reduce non-specific binding.
Antibody binding: Add 2-5μg of ywjG Antibody to 500-1000μg of pre-cleared lysate and incubate overnight at 4°C with gentle rotation.
Precipitation: Add Protein A/G beads and incubate for 2-4 hours at 4°C with gentle rotation.
Washing: Perform 4-5 sequential washes with wash buffer (similar to lysis buffer but with reduced detergent).
Elution: Elute bound proteins with SDS-PAGE sample buffer by heating at 95°C for 5 minutes.
Analysis: Analyze by SDS-PAGE followed by Western blotting or mass spectrometry.
This approach is consistent with established methods for detecting bacterial antigenic components using specific antibodies, where stable antigen-antibody complexes form under appropriate conditions .
For optimal Western blotting results with ywjG Antibody, follow these methodological guidelines:
Sample preparation: Extract proteins using a buffer containing 50mM Tris-HCl pH 8.0, 150mM NaCl, 1% Triton X-100, and protease inhibitors.
Protein separation: Load 10-30μg total protein per lane on a 10-12% SDS-PAGE gel.
Transfer conditions: Use PVDF membrane with semi-dry transfer at 15V for 30-45 minutes or wet transfer at 100V for 1 hour.
Blocking: Block with 5% non-fat dry milk or 3% BSA in TBST for 1 hour at room temperature.
Primary antibody incubation: Dilute ywjG Antibody 1:500-1:2000 in blocking solution and incubate overnight at 4°C.
Washing: Wash 3 times with TBST, 5-10 minutes each.
Secondary antibody: Use species-appropriate HRP-conjugated secondary antibody at 1:5000-1:10000 dilution for 1 hour at room temperature.
Detection: Use enhanced chemiluminescence (ECL) substrate and expose to X-ray film or digital imager.
Maintain consistent blocking and washing conditions to ensure reproducible results across experiments .
For immunofluorescence studies utilizing ywjG Antibody, the following protocol is recommended:
Culture preparation: Grow Bacillus subtilis strain 168 to mid-log phase (OD600 = 0.4-0.6).
Fixation: Fix cells with 4% paraformaldehyde for 15 minutes at room temperature, followed by permeabilization with 0.1% Triton X-100 for 10 minutes.
Blocking: Block with 3% BSA in PBS for 30 minutes.
Primary antibody: Apply ywjG Antibody at 1:100-1:500 dilution in blocking buffer and incubate overnight at 4°C.
Washing: Wash cells 3 times with PBS containing 0.05% Tween-20.
Secondary antibody: Incubate with fluorophore-conjugated secondary antibody (e.g., Alexa Fluor 488/594) at 1:500-1:1000 dilution for 1 hour at room temperature in the dark.
Counterstaining: Optionally stain DNA with DAPI (1μg/ml) for 5 minutes.
Mounting: Mount samples in anti-fade mounting medium.
Imaging: Analyze using confocal or fluorescence microscopy.
This method allows visualization of ywjG protein localization within the bacterial cell and potential co-localization with other cellular components .
Rigorous experimental controls are essential when working with ywjG Antibody to ensure valid and reliable results:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive Control | Confirm antibody reactivity | Include purified recombinant ywjG protein or known ywjG-expressing B. subtilis sample |
| Negative Control | Assess background and non-specific binding | Use ywjG knockout strain or unrelated bacterial species |
| Isotype Control | Evaluate non-specific binding of antibody class | Use same concentration of irrelevant antibody of same isotype |
| Secondary Antibody Only | Detect non-specific secondary antibody binding | Omit primary antibody while maintaining all other conditions |
| Loading Control | Normalize protein expression | Probe for housekeeping protein (e.g., 16S rRNA) |
| Pre-absorption Control | Validate specificity | Pre-incubate antibody with excess purified antigen before use |
| Competitive Binding | Confirm epitope specificity | Co-incubate with purified antigen and observe signal reduction |
These controls help distinguish between true signals and artifacts, ensuring that observed results are specifically attributable to ywjG antigen-antibody interactions .
For investigating protein-protein interactions involving the ywjG protein, researchers can employ several advanced methodologies:
Co-immunoprecipitation (Co-IP): Use ywjG Antibody to precipitate ywjG protein along with its interacting partners from bacterial lysates.
After standard IP procedure, identify co-precipitated proteins by mass spectrometry
Validate interactions by reciprocal Co-IP with antibodies against suspected partner proteins
Proximity Ligation Assay (PLA): Detect protein interactions with spatial resolution.
Co-incubate cells with ywjG Antibody and an antibody against a suspected interacting protein
Use species-specific PLA probes to generate fluorescent signals when proteins are in close proximity (<40nm)
Pull-down assays: Complement antibody-based approaches.
Express recombinant ywjG protein with an affinity tag
Capture protein complexes and analyze by Western blotting using ywjG Antibody to confirm interactions
Crosslinking mass spectrometry: For transient or weak interactions.
Chemically crosslink protein complexes in intact cells
Immunoprecipitate with ywjG Antibody and analyze by MS to identify interacting partners
These approaches align with methods described for analyzing protein interactions using bacterial-specific antibodies and can identify compounds that bind or interact with bacterial polypeptides .
When applying ywjG Antibody in cross-species experiments, researchers should consider several important factors:
This approach is consistent with biophysics-informed models for understanding antibody binding to related epitopes across different ligands .
ywjG Antibody can serve as a valuable tool in bacterial pathogenesis research through these methodological approaches:
Infection models: Use ywjG Antibody to track bacterial protein expression and localization during infection.
Immunostain infected tissue samples to visualize bacterial protein expression patterns
Analyze temporal changes in protein expression throughout infection progression
Bacterial adaptation studies: Monitor ywjG protein expression under different infection-relevant conditions.
Compare expression in standard culture versus host-mimicking conditions
Assess expression changes in response to antimicrobial treatments
Host-pathogen interaction analysis:
Use ywjG Antibody to visualize interactions between bacterial proteins and host cellular components
Perform co-localization studies with antibodies against host defense proteins
Diagnostic application development:
Employ ywjG Antibody in developing detection systems for bacterial infection
Develop ELISA or lateral flow assays for rapid bacterial identification in clinical samples
Virulence factor characterization:
Investigate potential correlations between ywjG expression and bacterial virulence
Study the role of ywjG in biofilm formation or host cell adhesion
These applications align with described diagnostic applications for detecting bacterial infection using bacterial-derived nucleic acids and their corresponding protein products .
ywjG Antibody can facilitate structural biology research through several sophisticated approaches:
Immunoelectron microscopy:
Fix bacterial cells using glutaraldehyde and osmium tetroxide
Embed in resin and prepare ultrathin sections
Incubate with ywjG Antibody followed by gold-conjugated secondary antibody
Visualize using transmission electron microscopy to determine subcellular localization with nanometer precision
Antibody-assisted crystallography:
Use ywjG Antibody fragments (Fab) to stabilize ywjG protein for crystallization
Co-crystallize protein-antibody complexes to facilitate X-ray diffraction studies
Solve crystal structures to understand protein conformation and functional domains
Single-particle cryo-EM facilitation:
Utilize ywjG Antibody to increase effective particle size for improved resolution
Employ antibody labeling to identify specific domains within larger complexes
Hydrogen-deuterium exchange mass spectrometry (HDX-MS):
Use ywjG Antibody to probe protein dynamics and conformational changes
Compare HDX patterns of free protein versus antibody-bound protein to identify binding interfaces
NMR epitope mapping:
Characterize antibody binding sites through chemical shift perturbations
Identify crucial residues involved in antibody recognition
These methods provide valuable insights into protein structure-function relationships and can guide rational design of antibodies with customized specificity profiles for different epitopes .
Non-specific binding can compromise experimental results when using ywjG Antibody. Here are methodological approaches to troubleshoot and minimize this issue:
Optimize blocking conditions:
Test different blocking agents (BSA, casein, normal serum, commercial blockers)
Increase blocking time (from 1 hour to overnight)
Add 0.1-0.3% Tween-20 to blocking buffer to reduce hydrophobic interactions
Adjust antibody concentration:
Perform titration experiments to determine optimal antibody dilution
Typical starting range: 1:500-1:2000 for Western blots; 1:50-1:200 for IHC/IF
Increase washing stringency:
Extend washing times (from 5 to 15 minutes per wash)
Increase salt concentration in wash buffer (from 150mM to 300mM NaCl)
Add 0.1-0.5% Triton X-100 or NP-40 to wash buffer
Pre-adsorption techniques:
Incubate antibody with protein extract from negative control samples
Use affinity-purified antibody when possible
Cross-reactivity assessment:
Test antibody against lysates from knockout strains or unrelated bacterial species
Perform Western blots on recombinant proteins with similar sequences
Buffer optimization:
Adjust pH conditions to optimal range (typically pH 7.2-7.6)
Add non-ionic detergents to reduce hydrophobic interactions
Include carrier proteins (0.1-0.5% BSA) in antibody dilution buffer
These approaches help distinguish specific signals from background, improving the reliability of results obtained with ywjG Antibody .
Signal variation in ywjG Antibody experiments can arise from multiple sources that must be systematically addressed:
| Variation Source | Manifestation | Mitigation Strategy |
|---|---|---|
| Sample Preparation | Inconsistent protein extraction | Standardize lysis buffer composition and extraction protocol |
| Protein Degradation | Unexpected bands or reduced signal | Add fresh protease inhibitors, maintain samples at 4°C |
| Antibody Batch Variation | Inconsistent results between experiments | Use same lot when possible, validate new lots against old standards |
| Incubation Conditions | Temperature fluctuations affecting binding kinetics | Maintain consistent temperature and timing |
| Detection System Variation | Inconsistent signal development | Standardize substrate preparation and exposure times |
| Protein Post-translational Modifications | Multiple bands or shifted migration | Use phosphatase or glycosidase treatments to confirm modification status |
| Expression Level Variations | Different signal intensities between bacterial cultures | Standardize growth conditions and harvest at consistent OD600 |
| Cross-Contamination | Unexpected signals in negative controls | Implement rigorous laboratory practices for reagent handling |
By systematically addressing these variables, researchers can achieve more consistent and reliable results when working with ywjG Antibody in various experimental contexts .
When applying ywjG Antibody to new experimental systems or conditions, validation of specificity is essential:
Multiple detection methods validation:
Confirm target detection using orthogonal techniques (Western blot, IP, IF)
Results should be consistent across different experimental approaches
Genetic validation approaches:
Test antibody against knockout or knockdown samples
Use overexpression systems to confirm increased signal
Compare wild-type vs. mutant strains with known alterations in the target
Peptide competition assays:
Pre-incubate antibody with excess immunizing peptide
Specific signal should be significantly reduced or eliminated
Mass spectrometry confirmation:
Immunoprecipitate with ywjG Antibody and analyze by MS
Confirm identity of detected proteins matches expected target
Cross-reactivity assessment:
Test against panel of related proteins or bacterial species
Evaluate signal in systems known to not express the target
Epitope mapping:
Use truncated or mutated protein constructs to confirm binding region
This can predict potential cross-reactivity with related proteins
These validation approaches ensure that experimental observations are genuinely attributable to ywjG protein, rather than artifacts or cross-reactivity, aligning with principles for generating specific antibodies that can discriminate between similar ligands .
When facing contradictory results in experiments using ywjG Antibody, systematic troubleshooting approaches include:
Comprehensive experimental review:
Audit all reagents, protocols, and experimental conditions
Document all deviations from standard protocols
Independent validation:
Repeat experiments with fresh reagents and independent sample preparation
Use multiple detection methods to cross-validate findings
Biological context assessment:
Review growth conditions, strain variations, and expression kinetics
Consider post-translational modifications that may affect antibody recognition
Technical parameter optimization:
Systematically vary antibody concentration, incubation times, and buffer conditions
Implement gradient approaches to identify optimal conditions
Alternative antibody validation:
When available, test alternative antibodies targeting different epitopes of ywjG
Compare monoclonal versus polyclonal antibody performance
Statistical analysis of reproducibility:
Perform multiple independent experiments (n≥3)
Apply appropriate statistical tests to determine significance of observations
Computational predictive models:
Use biophysics-informed models to understand potential binding modes
Identify factors that might influence antibody recognition in different contexts
This systematic approach mirrors the computational and experimental methods described for inferring antibody specificity and designing antibodies with custom specificity profiles .
Recent research applications of ywjG Antibody demonstrate its expanding utility in bacterial biology investigations:
Antimicrobial resistance studies:
Tracking ywjG expression changes in response to antibiotic exposure
Investigating potential role in antibiotic tolerance mechanisms
Screening for compounds that modulate ywjG function as potential antimicrobial targets
Bacterial cell biology:
Elucidating the role of ywjG in cell wall synthesis and remodeling
Studying localization patterns during different growth phases
Investigating interactions with other cell wall biosynthesis proteins
Comparative genomics applications:
Assessing expression of ywjG homologs across bacterial species
Correlating structural variations with functional differences
Evolutionary analysis of protein conservation across bacterial phyla
Host-pathogen interaction research:
Examining ywjG expression during infection processes
Investigating potential immunomodulatory effects
Studying bacterial adaptation mechanisms in host environments
Diagnostic technology development:
Creating sensitive detection systems for bacterial identification
Developing multiplex assays for bacterial speciation
Engineering improved antibody variants for enhanced detection sensitivity
These applications demonstrate the versatility of ywjG Antibody as a research tool across multiple disciplines in bacterial biology, consistent with approaches for developing diagnostic reagents for bacterial infection .
Emerging technologies are expanding the potential applications and improving the performance of ywjG Antibody in research:
Single-cell antibody-based technologies:
Single-cell Western blotting for heterogeneity assessment
Mass cytometry (CyTOF) for multiparameter protein analysis
Microfluidic antibody capture for rare cell detection
Advanced imaging techniques:
Super-resolution microscopy (STORM, PALM) for nanoscale localization
Expansion microscopy for improved spatial resolution
Live-cell imaging with genetically incorporated epitope tags
Next-generation antibody engineering:
Computational design of antibodies with enhanced specificity
Nanobody and single-domain antibody development
Bispecific antibodies for simultaneous targeting of multiple antigens
High-throughput screening platforms:
Antibody arrays for proteomic profiling
Automated immunoassay systems for large-scale studies
Machine learning algorithms for pattern recognition in antibody binding data
Antibody-drug conjugate approaches:
Targeted delivery of antimicrobial compounds
Specific labeling of bacterial cells for enhanced detection
Selective elimination of specific bacterial populations
These technological advancements align with biophysics-informed modeling approaches for designing antibodies with customized specificity profiles, enabling more precise and sensitive research applications .
ywjG Antibody offers significant potential in antimicrobial resistance research through several methodological approaches:
Resistance mechanism characterization:
Monitor ywjG expression changes in resistant versus susceptible strains
Investigate protein localization alterations under antibiotic pressure
Examine potential post-translational modifications associated with resistance
Target validation studies:
Use antibody-mediated inhibition to assess functional significance
Identify bacterial strains with variations in ywjG expression or structure
Correlate ywjG characteristics with antimicrobial susceptibility profiles
High-throughput screening applications:
Develop antibody-based assays to screen compound libraries
Identify molecules that modulate ywjG expression or activity
Select compounds that bind to bacterial targets as potential antimicrobial candidates
Combination therapy investigations:
Study effects of existing antibiotics on ywjG expression and localization
Identify synergistic approaches targeting ywjG and related pathways
Develop strategies to overcome resistance mechanisms
In vivo infection model applications:
Track ywjG expression during infection progression
Monitor effects of antimicrobial treatment on protein dynamics
Correlate ywjG status with treatment efficacy and resistance development
These approaches align with methods described for screening test compounds for anti-bacterial activity by targeting bacterial-specific sequences essential for viability , potentially leading to novel strategies for combating antimicrobial resistance.